E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes

被引:37
作者
Dicker, AJ [1 ]
Popa, C [1 ]
Dahler, AL [1 ]
Serewko, MM [1 ]
Hilditch-Maguire, PA [1 ]
Frazer, IH [1 ]
Saunders, NA [1 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Med, Ctr Immunol & Canc Res,Epithelial Pathobiol Grp, Brisbane, Qld 4102, Australia
基金
英国医学研究理事会;
关键词
keratinocyte; E2F-1; differentiation; carcinogenesis;
D O I
10.1038/sj.onc.1203610
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Squamous differentiation of keratinocytes is associated with decreases in E2F-1 mRNA expression and E2F activity, and these processes are disrupted in squamous cell carcinoma cell lines. We now show that E2F-1 mRNA expression is increased in primary squamous cell carcinomas of the skin relative to normal epidermis, To explore the relationship between E2F-1 and squamous differentiation further, we examined the effect of altering E2F activity in primary human keratinocytes induced to differentiate. Promoter activity for the proliferation-associated genes, cdc2 and keratin 14, are inhibited during squamous differentiation. This inhibition can be inhibited by overexpression of E2F-1 in keratinocytes, Overexpression of E2F-1 also suppressed the expression of differentiation markers (transglutaminase type 1 and keratin 10) in differentiated keratinocytes, Blocking E2F activity by transfecting proliferating keratinocytes with dominant negative E2F-1 constructs inhibited the expression of cdc2 and E2F-1, but did not induce differentiation. Furthermore, expression of the dominant negative construct in epithelial carcinoma cell lines and normal keratinocytes decreased expression from the cdc2 promoter. These data indicate that E2F-1 promotes keratinocyte proliferation-specific marker genes and suppresses squamous differentiation-specific marker genes. Moreover, these data indicate that targeted disruption of E2F-1 activity may have therapeutic potential for the treatment of squamous carcinomas.
引用
收藏
页码:2887 / 2894
页数:8
相关论文
共 85 条
[1]   AN UNUSUAL STRAIN OF HUMAN KERATINOCYTES WHICH DO NOT STRATIFY OR UNDERGO TERMINAL DIFFERENTIATION IN CULTURE [J].
ADAMS, JC ;
WATT, FM .
JOURNAL OF CELL BIOLOGY, 1988, 107 (05) :1927-1938
[2]   SKN-1A AND SKN-1I - 2 FUNCTIONALLY DISTINCT OCT-2-RELATED FACTORS EXPRESSED IN EPIDERMIS [J].
ANDERSEN, B ;
SCHONEMANN, MD ;
FLYNN, SE ;
PEARSE, RV ;
SINGH, H ;
ROSENFELD, MG .
SCIENCE, 1993, 260 (5104) :78-82
[3]  
Arany I, 1997, IN VIVO, V11, P157
[4]   SKIN HYPERKERATOSIS AND PAPILLOMA FORMATION IN TRANSGENIC MICE EXPRESSING A RAS ONCOGENE FROM A SUPRABASAL KERATIN PROMOTER [J].
BAILLEUL, B ;
SURANI, MA ;
WHITE, S ;
BARTON, SC ;
BROWN, K ;
BLESSING, M ;
JORCANO, J ;
BALMAIN, A .
CELL, 1990, 62 (04) :697-708
[5]   Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor [J].
Bandara, LR ;
Girling, R ;
LaThangue, NB .
NATURE BIOTECHNOLOGY, 1997, 15 (09) :896-901
[6]   E2F-4, A NEW MEMBER OF THE E2F GENE FAMILY, HAS ONCOGENIC ACTIVITY AND ASSOCIATES WITH P107 IN-VIVO [J].
BEIJERSBERGEN, RL ;
KERKHOVEN, RM ;
ZHU, LA ;
CARLEE, L ;
VOORHOEVE, PM ;
BERNARDS, R .
GENES & DEVELOPMENT, 1994, 8 (22) :2680-2690
[7]   HA-RAS P21-CTP LEVELS REMAIN CONSTANT DURING PRIMARY KERATINOCYTE DIFFERENTIATION [J].
BETZ, NA ;
PELLING, JC .
MOLECULAR CARCINOGENESIS, 1995, 12 (02) :66-76
[8]   Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: Inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions [J].
Blessing, M ;
Schirmacher, P ;
Kaiser, S .
JOURNAL OF CELL BIOLOGY, 1996, 135 (01) :227-239
[9]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[10]  
BUCK V, 1995, ONCOGENE, V11, P31